Cargando…
Pharmacogenomically actionable medications in a safety net health care system
OBJECTIVE: Prior to implementing a trial to evaluate the economic costs and clinical outcomes of pharmacogenetic testing in a large safety net health care system, we determined the number of patients taking targeted medications and their clinical care encounter sites. METHODS: Using 1-year electroni...
Autores principales: | Carpenter, Janet S, Rosenman, Marc B, Knisely, Mitchell R, Decker, Brian S, Levy, Kenneth D, Flockhart, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724767/ https://www.ncbi.nlm.nih.gov/pubmed/26835014 http://dx.doi.org/10.1177/2050312115624333 |
Ejemplares similares
-
Patients Dispensed Medications with Actionable Pharmacogenomic Biomarkers: Rates and Characteristics
por: Liu, Dianbo, et al.
Publicado: (2021) -
Pharmacogenomics of the Efficacy and Safety of Colchicine in COLCOT
por: Dubé, Marie-Pierre, et al.
Publicado: (2021) -
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
por: Genovesi, Laura A., et al.
Publicado: (2021) -
Pharmacogenomics of Medications Commonly Used in the Intensive Care Unit
por: Zhou, Shuqin, et al.
Publicado: (2018) -
Pharmacogenomics in oncology care
por: Filipski, Kelly K., et al.
Publicado: (2014)